Respiratory

REACH is an experienced thought leader in the respiratory space. Our team has conducted research across many respiratory diseases, both rare and non-rare.

DISEASES WE COVER

The respiratory space has evolved from a focus on mass market opportunities like COPD and asthma to growing pharmaceutical interest in smaller patient populations as validated by Vertex’s franchise in Cystic Fibrosis. Current respiratory dynamics the REACH team is tracking include:

  • Device and formulation improvements in asthma and COPD
  • The increasing global prevalence of respiratory illness
  • Growing pharmaceutical interest in niche and rare respiratory diseases such as Alpha-1 Antitrypsin Deficiency, Pulmonary Sarcoidosis and Interstitial Lung Disease
See our rare respiratory solutions

Search Respiratory diseases we cover

Disease
Acute Respiratory Distress Syndrome
Acute Respiratory Distress Syndrome
Alpha-1 Antitrypsin Deficiency
Alpha-1 Antitrypsin Deficiency
Cystic Fibrosis
Cystic Fibrosis
Idiopathic Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis
Severe Asthma
Severe Asthma
Don’t see your disease of interest? Don’t worry! Our experienced team can provide market research support for any rare disease. Reach out to learn how we can help.
Disease
Acute Respiratory Distress Syndrome
Acute Respiratory Distress Syndrome
Alpha-1 Antitrypsin Deficiency
Alpha-1 Antitrypsin Deficiency
Cystic Fibrosis
Cystic Fibrosis
Don’t see your disease of interest? Don’t worry! Our experienced team can provide market research support for any rare disease. Reach out to learn how we can help.
Browse contacts:
1 2

Schedule a respiratory demo with our team

OUR SOLUTIONS

Market Landscape Assessment

MarketVue® reports capture the current and anticipated future state of any rare respiratory market

Learn More

Epidemiology

EpiVue® reports quantify prevalence, diagnosis, treatment rates and patient segments for rare respiratory conditions

Learn More

Indication Prioritization

MarketSheet® single-sheet market primers for any respiratory disease allow easy comparison across the respiratory therapy area

Learn More

Custom Rapid Insights

Fast turnaround primary market research for a focused set of questions for pulmonologists or payers

Learn More

Reach out to our team to learn more about our capabilities and view sample reports.

Contact us